Integrating a Mobility Champion in the Intensive Care Unit

Dimensions of Critical Care Nursing : DCCN
Rose Bruce, Cheryl Forry

Abstract

In recent years, early progressive mobilization programs have become mainstays in intensive care units (ICUs). Significant evidence exists that early mobility programs decrease length of stay, reduce time on the ventilator, and decrease the development of delirium in ICU patients. Yet, current literature still describes many barriers to performing early mobility, such as the time required, staffing pressures, and increased workload. Our critical care leaders found that defining and implementing a dedicated mobility champion team member was successful in improving the effectiveness of our early mobility program. This article describes how to define the mobility champion role, consider options for the person in the role, and integrate this new role into the ICU team.

References

Apr 9, 2004·Critical Care Medicine·Eric B MilbrandtE Wesley Ely
Apr 13, 2010·Archives of Physical Medicine and Rehabilitation·Dale M NeedhamEddy Fan
Apr 19, 2011·PM & R : the Journal of Injury, Function, and Rehabilitation·Jaime Garzon-SerranoMatthias Eikermann
May 31, 2011·Journal of Emergency Nursing : JEN : Official Publication of the Emergency Department Nurses Association·Carole L White
Apr 3, 2012·Journal of Neurosurgery·W Lee TitsworthJ Mocco
Dec 24, 2014·Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses·Elizabeth A BarberCarol L Hodgson
Aug 6, 2015·Dimensions of Critical Care Nursing : DCCN·Stacey L KramRuth Ann Jones
May 6, 2016·Annals of the American Thoracic Society·Rolf DubbDale M Needham
May 7, 2016·AACN Advanced Critical Care·Ramona O HopkinsSamuel M Brown
Oct 18, 2016·Dimensions of Critical Care Nursing : DCCN·Leanne M BoehmLorraine C Mion

❮ Previous
Next ❯

Citations

Aug 21, 2021·Enfermería intensiva·L O Gómez TovarI Y Troche-Gutiérrez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.